Hemogenyx Pharmaceuticals PLC (HEMO) — Cash Flow Reinvestment Rate

Latest as of June 2017: 0.47x

Hemogenyx Pharmaceuticals PLC (HEMO) has a Cash Flow Reinvestment Rate of 0.47x as of June 2017, reinvesting GBX11.02 (capex GBX11.02 ) from operating cash flow of GBX23.26. Check earnings quality score of Hemogenyx Pharmaceuticals PLC to evaluate the quality of earnings relative to operating cash generation.

Reinvestment Rate

0.47x

(Capex + Investments) / Operating CF

Total Reinvested

GBX11.02

Capex + Investments

Operating Cash Flow

GBX23.26

GBX

Capital Expenditures

GBX11.02

GBX

Hemogenyx Pharmaceuticals PLC Cash Flow Reinvestment Rate (2015–2015)

Historical reinvestment intensity for Hemogenyx Pharmaceuticals PLC across 1 annual periods. Explore debt repayment capacity of Hemogenyx Pharmaceuticals PLC to assess how comfortably operating cash covers total debt obligations.

Annual Cash Flow Reinvestment Rate for Hemogenyx Pharmaceuticals PLC (2015–2015)

Year-by-year capital reinvestment analysis for Hemogenyx Pharmaceuticals PLC. For live market cap and broader valuation context, see market cap of Hemogenyx Pharmaceuticals PLC.

Year	Reinvestment Rate	Total Reinvested (GBX)	Operating CF	Capex	YoY Change
2015	0.00x	GBX0.00	GBX79.71	GBX0.00	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow